chlorzoxazone has been researched along with Dyspepsia in 1 studies
Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.
Dyspepsia: Impaired digestion, especially after eating.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lasofoxifene was tested in 18 postmenopausal women with probe drugs for CYP2E1 and CYP2D6." | 2.72 | Effects of steady-state lasofoxifene on CYP2D6- and CYP2E1-mediated metabolism. ( Fisher, JM; Gardner, MJ; Kolluri, S; Moller, RA; Obach, RS; Taylor, AE; Walsky, RL, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moller, RA | 1 |
| Fisher, JM | 1 |
| Taylor, AE | 1 |
| Kolluri, S | 1 |
| Gardner, MJ | 1 |
| Obach, RS | 1 |
| Walsky, RL | 1 |
1 trial available for chlorzoxazone and Dyspepsia
| Article | Year |
|---|---|
Effects of steady-state lasofoxifene on CYP2D6- and CYP2E1-mediated metabolism.
Topics: Administration, Oral; Chlorzoxazone; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cy | 2006 |